STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

Shareholder plans sale of 200000 CRWV (NASDAQ: CRWV) shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV filed a Form 144 notice covering the proposed sale of 200000 shares of common stock, with an aggregate market value of $16662000.00, to be sold through Morgan Stanley Smith Barney LLC on or after 07/14/2026 on NASDAQ.

The shares to be sold were acquired on 02/25/2019 via a Preferred Stock Conversion from the issuer. Total common shares outstanding were 447573939; this is a baseline figure, not the amount being offered. The disclosure also lists numerous recent transactions, including Rule 10b5-1 sales by holders such as Michael Intrator and Omnadora Capital LLC.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 200000 shares Common stock to be sold through Morgan Stanley Smith Barney LLC
Aggregate market value of proposed sale $16662000.00 Total market value of the 200000 shares covered by the notice
Shares outstanding 447573939 shares Total common shares outstanding referenced in the Form 144
Proposed sale date 07/14/2026 Date on or after which the 200000-share sale may occur on NASDAQ
Acquisition date of shares 02/25/2019 Date the 200000 shares were acquired via Preferred Stock Conversion
Example 10b5-1 sale proceeds $19666200.00 Proceeds from a 200000-share Rule 10b5-1 sale by Michael Intrator on 05/19/2026
10b5-1 Sales regulatory
"10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave."
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Preferred Stock Conversion financial
"Common | 02/25/2019 | Preferred Stock Conversion | Issuer"
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does CRWV's Form 144 filing disclose about planned share sales?
The filing discloses a planned sale of 200000 CRWV common shares, with an aggregate market value of $16662000.00, to be executed through Morgan Stanley Smith Barney LLC on or after 07/14/2026 on the NASDAQ market.

How many CRWV shares are outstanding according to this Form 144?
The Form 144 states that CRWV has 447573939 common shares outstanding. This figure provides context for the proposed 200000-share sale and helps investors gauge its relative size versus the company’s total share base.

How were the CRWV shares covered by the Form 144 originally acquired?
The 200000 CRWV common shares covered by the notice were acquired on 02/25/2019 through a Preferred Stock Conversion from the issuer. This indicates the holder received common stock in exchange for previously held preferred shares.

When is the proposed sale date for the CRWV shares in this Form 144?
The Form 144 lists 07/14/2026 as the date for the proposed sale of 200000 CRWV common shares. This is the date on or after which the filing holder expects to execute the transaction on NASDAQ through the named broker.

What recent Rule 10b5-1 trading activity in CRWV is described?
The disclosure lists multiple Rule 10b5-1 sales of CRWV common stock over the past three months by holders including Michael Intrator and Omnadora Capital LLC, with individual trades such as 200000 shares sold on 05/19/2026 for $19666200.00.

Which broker is handling the proposed CRWV share sale in the Form 144?
The proposed sale of 200000 CRWV common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004, as specified in the Form 144 details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR